Amarin Corp. has received FDA approval of its sNDA to add Chemport as an additional API supplier for Vascepa (icosapent ethyl). The addition of Chemport contributes to the expansion of Vascepa’s manufacturing supply chain and to Amarin’s goal to protect the commercial potential of Vascepa beyond 2030 through a combination of patent protection and regulatory exclusivity.   “This sNDA approval of Chemport as a supplier of Vascepa marks another significant step for Amarin toward the goa...